In NAFLD animal models, FoxO1 activity has been demonstrated to be essential for maintaining lipid homeostasis, underscoring its beneficial metabolic functions [118]. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.